Therefore, the downregulation of MMP9 in the PBMCs from patients with pulmonary sarcoidosis with EPL might indicate the different pathobiological features between extrapulmonary and pulmonary sarcoidosis. This evidence concerns the gene MMP9 and pulmonary sarcoidosis.